Sort
261,768 grants matching “gene therapy”
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
$2,122,802Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2019 · CA
Translational Platform for Epilepsy Therapy and Biomarker Discovery
$2,122,350Aristea S Galanopoulou · Albert Einstein College Of Medicine · R01 · FY2023 · NS
Cardiac Fibrillation: Mechanisms and Therapy
$2,122,293James N Weiss · University Of California Los Angeles · P01 · FY2014 · HL
Regulatory and epigenetic landscapes reveal biological processes, disease mechanisms and diagnostic markers
$2,121,366Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2025 · HG
METAGENOMIC ENGINEERING OF PROBIOTIC BACTERIA TO IMPROVE INTESTINAL COLONIZATION
$2,120,967Gautam Dantas · Washington University · DP2 · FY2012 · DK
Gene Therapy for Sickle Cell Disease
$2,120,936Arthur W. Nienhuis · St. Jude Children'S Research Hospital · P01 · FY2007 · HL
Discovery And Functional Genomics Of Environmental Response Genes
$2,120,911Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Brain Tumor Clinical and Clinical Research Program
$2,120,708Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2024 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,120,700Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Molecular, Cellular and Circuit Mechanisms for Age-Related Deficits in Memory-Linking
$2,120,292Alcino J. Silva · University Of California Los Angeles · RF1 · FY2022 · AG
Mayo Clinic Multiple Myeloma SPORE
$2,120,249Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2019 · CA
Targeting Lung Cancer Vulnerabilities
$2,120,114John D Minna · Ut Southwestern Medical Center · P50 · FY2022 · CA
Selective Targeting of Pancreatic Cancer SPORE
$2,120,012Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data
$2,120,004Howard A Fine · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface
$2,119,522Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Surgery Branch Cell Prep Core
$2,119,096Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Cell Production Core Facility
$2,119,096Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
The role of stem cells in skeletal health and disease
$2,118,894Pamela G Robey · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Dysregulation of Multivesicular Body and Exosome Flux in Alzheimer's Disease
$2,118,687Zixu Mao · Emory University · RF1 · FY2021 · AG
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
$2,117,897Lisa Rimsza · Mayo Clinic Arizona · P01 · FY2021 · CA
Specialized Program Of Research Excellence (SPORE) in Leukemia.
$2,117,606Daniel C Link · Washington University · P50 · FY2019 · CA
Xenobiotic induction mechanisms affecting pharmacokinetics and pharmacodynamics among medically complex children, adolescents, and young adults.
$2,117,500Jonathan Eric Constance · Utah State Higher Education System--University Of Utah · R35 · FY2025 · GM
Mechanisms and Markers of Prostate Cancer Metastases
$2,117,386University Of Washington · P01 · FY2005 · CA
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$2,117,192Shivinder S Grewal · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,117,028Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL